Neogen Corporation Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Neogen Corporation (NEOG) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $5.40 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-07-30
- 2026-05-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.40M.
- 2025-05-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.32M.
- 2024-05-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.62M.
- 2023-05-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.81M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-05-31 | $5.40M 10-K · filed 2026-07-30 |
| 2025-05-31 | $5.32M 10-K · filed 2025-07-30 |
| 2024-05-31 | $2.62M 10-K · filed 2024-07-30 |
| 2023-05-31 | $1.81M 10-K · filed 2023-08-15 |
| 2022-05-31 | $88.00K 10-K · filed 2022-07-27 |
| 2021-05-31 | $82.00K 10-K · filed 2021-07-30 |
| 2021-02-28 | $84.00K 10-Q · filed 2021-03-31 |
| 2020-11-30 | $101.00K 10-Q · filed 2020-12-29 |
| 2020-08-31 | $97.00K 10-Q · filed 2020-09-30 |
| 2020-05-31 | $112.00K 10-K · filed 2020-07-30 |
| 2020-02-29 | $58.00K 10-Q · filed 2020-04-03 |
| 2019-11-30 | $114.00K 10-Q · filed 2019-12-27 |
| 2019-08-31 | $44.00K 10-Q · filed 2019-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |